GeneDx (WGSWW) Expected to Announce Quarterly Earnings on Monday
by Doug Wharley · The Cerbat GemGeneDx (NASDAQ:WGSWW – Get Free Report) is projected to issue its resultson Monday, May 4th. Analysts expect the company to announce earnings of ($0.0150) per share and revenue of $112.4540 million for the quarter.
GeneDx Price Performance
GeneDx stock opened at $0.01 on Monday. The business has a 50 day moving average of $0.01 and a 200-day moving average of $0.04. GeneDx has a 1 year low of $0.00 and a 1 year high of $0.19.
GeneDx Company Profile
GeneDx is a molecular diagnostics company specializing in high-complexity genetic testing for rare and ultra-rare inherited disorders. The company leverages next-generation sequencing (NGS) technologies, including whole exome sequencing, targeted gene panels, and chromosomal microarray analysis, to deliver comprehensive diagnostic insights. Its services are designed to support clinicians in identifying genetic mutations that underlie pediatric and adult conditions, guiding patient management, treatment decisions, and genetic counseling.
Founded in 2000 by Dr.